Non-Invasive Transplant Check
The aim is to launch a new therapeutic method for sports medicine using a combination of new combined laser therapeutic device with adequate therapies and limited quantities of corresponding drugs.
To develop, manufacture, test and introduce to the market a completely new type of medical device for vacuum therapy.
Production and testing of biomedical shape memory alloys, development of suitable training methods and devices to induce the 2-way shape memory effect, and investigation of its long-term stability and testing of alloy biocompatibility.
Apart from in humans, iron deficiency is still a major problem in several segments of the livestock industry, with piglet anaemia as the most widespread. The main objective of this project is to develop a new hem-iron product obtained from pig blood waste in slaughterhouses.
The aim of the project is the development of a new generation of medical lasers with integrated real-time monitoring systems for determining optimal laser treatment parameters based on tissue changes during treatment. Integrated tissue monitoring will result in increased safety and efficacy.
The purpose of this project is the study, the interpretation and the utilisation of the effects of migration that an ultrasound field produces in inclusions of micro and nano bubbles, with therapeutic purpose in different medicine fields.
A clinically relevant test with the corresponding equipment and laboratory material will be developed to determine microvesicles (sub-micron fragments of cells) from blood for diagnostics and treatment. The market consists of research and clinical laboratories worldwide.
A novel biomimetic bioreactor for biomaterial/tissue characterization/cultivation under precisely defined conditions mimicking those in intervertebral discs will be constructed. Bioreactor optimization will be performed in conjunction with development and assessment of novel biomedical biomaterials.
The primary goal of the project evita is to develop an innovative dermatological product formulation dermavit for treatment of specific severe cutaneous side effects induced by therapy in oncology patients and to improve their quality of life.